KYTX Dividend: Kyverna Therapeutics Inc Yield Insights
Back
Home
Stock
KYTX
Kyverna Therapeutics Inc (KYTX) Price
KYTX Stock Price Chart
KYTX Financial
Kyverna Therapeutics Inc
$9.4
4.56%
$0.41
At close: Dec 26, 16:00:00 GMT-5
$9.37
-0.31%
$-0.03
Post-market: Dec 26, 17:48:21 GMT-5
Overview
Forecast
Earnings
Dividends
Financials
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Market Sentiment
Technical Analysis
Crypto Comparison
Home Page
Trading Strategies
Megabrain Investors Picks
Trading Mindshare
Technical Signals
Pivot Alert
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
Stocks Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2025 Finture Development Limited. All rights reserved
Ask AI About KYTX
Ask a question to get started...
Income
Balance sheet
Cash flow
Annual
Quarterly
KYTX Income
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
0
0
0
7
5
Revenue Growth (YoY)
--
--
-100%
40%
--
Cost of Revenue
--
--
--
--
--
Gross Profit
--
--
--
--
--
Selling, General & Admin
34
30
12
8
6
Research & Development
137
--
49
28
25
Operating Expenses
171
143
62
36
32
Other Non Operating Income (Expenses)
0
16
0
0
0
Pretax Income
-160
-127
-60
-28
-26
Income Tax Expense
--
--
--
--
--
Net Income
-160
-127
-60
-28
-26
Net Income Growth
44%
112%
113.99%
8%
--
Shares Outstanding (Diluted)
43.41
38
43.11
40.82
40.82
Shares Change (YoY)
1%
-12%
6%
0%
--
EPS (Diluted)
-3.72
-3.33
-1.4
-0.71
-0.65
EPS Growth
45%
138%
97%
9%
--
Free Cash Flow
-158
-116
-53
-36
-23
Free Cash Flow Per Share
-3.63
-3.05
-1.22
-0.88
-0.56
Gross Margin
--
--
--
--
--
Operating Margin
0%
0%
0%
-414.28%
-520%
Profit Margin
0%
0%
0%
-400%
-520%
Free Cash Flow Margin
0%
0%
0%
-514.28%
-459.99%
EBITDA
-170
-141
-61
-28
-26
EBITDA Margin
0%
0%
0%
-400%
-520%
D&A For EBITDA
1
2
1
1
0
EBIT
-171
-143
-62
-29
-26
EBIT Margin
0%
0%
0%
-414.28%
-520%
Effective Tax Rate
--
--
--
--
--
Follow-Up Questions
What are Kyverna Therapeutics Inc's key financial statements?
What are the key financial ratios for KYTX?
How is Kyverna Therapeutics Inc's revenue broken down by segment or geography?
Is Kyverna Therapeutics Inc profitable?
Does Kyverna Therapeutics Inc have any liabilities?
How many outstanding shares for Kyverna Therapeutics Inc?